Company overview
Monopar Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics for the treatment of cancer in the United States. The company develops ALXN1840, a late-stage, investigational once-daily and oral medicine; MNPR-101, a proprietary humanized monoclonal antibody that is conjugated with different radioisotopes for the treatment of advanced solid tumors expressing urokinase plasminogen activator receptor; and MNPR-101-Zr, a clinical-stage radiodiagnostic imaging agent comprised of MNPR-101 conjugated to zirconium-89. It develops MNPR-101-Lu, a late-preclinical stage radiotherapeutic comprised of MNPR-101 conjugated to actinium-225. The company has collaborations NorthStar to develop radio-immuno-therapeutics targeting severe COVID-19. The company was founded in 2014 and is headquartered in Wilmette, Illinois.
Daily valuation snapshot
These values come from the daily market snapshot dated 2026-10-08. TTM means trailing twelve months. Use the market date when comparing MNPR with another company.
| Daily close (USD) | $83.98 |
| Market capitalization (USD) | $563,688,204.56 |
| Price / earnings (TTM) | Not reported |
| Price / book | 4.31 |
No matching rows. Clear the filter to see all records.
Read MNPR's valuation metrics
Company size
Monopar Therapeutics Inc. Common Stock's recorded market capitalization is $563,688,204.56. It measures the market value of the company's equity, rather than its revenue or cash balance.
Price relative to earnings
P/E compares share price with trailing annual earnings per share. For a company with losses, inspect the earnings figures directly rather than treating a negative multiple as a cheap valuation.
Price relative to book equity
MNPR's recorded price-to-book ratio is 4.31. That compares its market equity value with recorded book equity. Examine its business and balance sheet to understand why those values differ.
Research Monopar Therapeutics Inc. Common Stock with Aurora
Use the snapshot above to ask a specific question about MNPR. Ask for the report period and the figures behind the explanation, then compare the answer with the company's business description.
Continue the research
Follow MNPR's ownership disclosures to see who filed a transaction or position and when it became public. To turn a research idea into a strategy, define an entry rule and test its dated observations.